Bijuva
Payments companies reported to CMS as associated with Bijuva. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bijuva, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bijuva
These are the largest totals companies reported as associated with Bijuva. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Risa Kagan | Berkeley, CA | Obstetrics & Gynecology | $50,272.54 |
| James Simon | Washington, DC | Gynecology | $45,133.15 |
| Elliot Cazes | Tampa, FL | Obstetrics & Gynecology | $41,342.91 |
| Sharon Winer | Beverly Hills, CA | Reproductive Endocrinology | $40,514.49 |
| Lisa Larkin | Cincinnati, OH | Internal Medicine | $34,818.91 |
| Mark Firestone | Aventura, FL | Obstetrics & Gynecology | $33,805.69 |
| Jay Cohen | Plantation, FL | Obstetrics & Gynecology | $33,662.38 |
| Daisy Ayim | Houston, TX | Obstetrics & Gynecology | $32,136.82 |
| Becky Lynn | Saint Louis, MO | Obstetrics & Gynecology | $31,938.52 |
| Andrew London | Lutherville, MD | Gynecology | $31,890.46 |
Prescribed Bijuva?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.